Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision changed from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T04:45:03.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T17:32:19.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Updated the study site list with many new locations and institutions, and removed several previously listed sites. The total number of locations is now 264.
    Difference
    3%
    Check dated 2026-02-28T12:39:18.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions list and a Genetic and Rare Diseases Information Center resource was linked in Resources. The page revision is updated to v3.4.2 from v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T05:11:05.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI/version changes not affecting study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T04:46:29.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Show glossary was added; update-related items (Last Update Submitted that Met QC Criteria and Last Update Posted) are displayed, and the page revision updated to Revision: v3.4.0, while older labeling such as No FEAR Act data and the previous revision text were removed.
    Difference
    0.1%
    Check dated 2026-01-23T22:35:49.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.